RECCHIUTI, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 2.030
EU - Europa 1.510
AS - Asia 916
SA - Sud America 65
AF - Africa 16
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.547
Nazione #
US - Stati Uniti d'America 1.988
SG - Singapore 374
IT - Italia 342
CN - Cina 255
IE - Irlanda 249
SE - Svezia 216
UA - Ucraina 182
TR - Turchia 135
GB - Regno Unito 125
DE - Germania 117
FR - Francia 88
IN - India 71
BR - Brasile 57
FI - Finlandia 51
RU - Federazione Russa 43
AT - Austria 41
CA - Canada 28
HK - Hong Kong 21
VN - Vietnam 20
NL - Olanda 13
BE - Belgio 12
BZ - Belize 12
EG - Egitto 10
AU - Australia 9
IR - Iran 9
KR - Corea 9
ES - Italia 7
JP - Giappone 7
CZ - Repubblica Ceca 6
AR - Argentina 4
IL - Israele 3
MA - Marocco 3
PL - Polonia 3
PT - Portogallo 3
TW - Taiwan 3
EE - Estonia 2
HR - Croazia 2
KE - Kenya 2
PK - Pakistan 2
RO - Romania 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
EC - Ecuador 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
ID - Indonesia 1
IQ - Iraq 1
JM - Giamaica 1
LT - Lituania 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
SN - Senegal 1
UZ - Uzbekistan 1
Totale 4.547
Città #
Chandler 366
Singapore 263
Dublin 247
Jacksonville 228
Princeton 109
Ashburn 98
Dearborn 94
Southend 88
New York 80
Izmir 77
Ann Arbor 74
Pescara 73
The Dalles 68
Wilmington 66
Nanjing 62
Boardman 56
Santa Clara 52
Beijing 46
Chieti 43
Altamura 41
Rome 37
Vienna 33
Woodbridge 32
Houston 29
Cambridge 28
Nuremberg 22
San Mateo 22
Washington 22
Augusta 21
Nanchang 21
Los Angeles 19
Dong Ket 17
Helsinki 17
Munich 16
Montreal 14
Brussels 12
Central 12
Falls Church 12
Ancona 11
Naples 11
Shenyang 11
Toronto 11
Jiaxing 10
Lappeenranta 10
Tianjin 10
Cairo 9
Hong Kong 9
Seattle 9
Ascoli Piceno 8
Milan 8
Kunming 7
Shanghai 7
Changsha 6
Düsseldorf 6
Jinan 6
Redwood City 6
Amsterdam 5
Hangzhou 5
Hebei 5
Jundiaí 5
Melbourne 5
Norwalk 5
Prato 5
Tokyo 5
Brno 4
Camerino 4
Falkenstein 4
Frankfurt am Main 4
Frederick 4
Grevenbroich 4
Leawood 4
Mapo-gu 4
Napoli 4
Ningbo 4
Rochester 4
Saint-Saens 4
Verona 4
Alba 3
Auburn Hills 3
Dacun 3
Lanciano 3
Modena 3
Phoenix 3
Saskatoon 3
Taizhou 3
Tappahannock 3
Woburn 3
Aprilia 2
Belgrade 2
Belo Horizonte 2
Blumenau 2
Campobasso 2
Carinola 2
Castignano 2
Chaoyang 2
Chicago 2
Chongqing 2
Cologna Veneta 2
Delhi 2
Denver 2
Totale 2.920
Nome #
Lipoxin A4 stimulates endothelial miR-126-5p expression and its transfer via microvesicles 155
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection 137
Establishment and long-term culture of human cystic fibrosis endothelial cells 133
Mechanisms of endothelial cell dysfunction in cystic fibrosis 128
Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation. 124
Resolvin D1 improves airway inflammation and exercise capacity in cystic fibrosis lung disease. 121
MicroRNA-181b regulates ALX/FPR2 expression and proresolution signaling in human macrophages. 114
Anti-inflammatory and pro-resolving properties of benzo-lipoxin A(4) analogs. 107
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 106
Resolvin D1 binds human phagocytes with evidence for proresolving receptors. 105
Lipoxins, resolvins, and the resolution of inflammation 104
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 103
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 101
Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity 100
MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits. 99
Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages. 98
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. 97
microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A4 receptor-dependent mechanisms of inflammation resolution and antimicrobial defense. 97
Resolvin D1 promotes resolution of inflammation, infection, and damage in CF 94
Novel anti-inflammatory--pro-resolving mediators and their receptors. 93
Lipoxin receptors 92
RESOLVIN D1 FOR TARGETING LUNG INFLAMMATION, INFECTION, AND DAMAGE IN CF 91
HARNESSING RESOLUTION MEDIATORS AS NOVEL THERAPEUTICS FOR CYSTIC FIBROSIS 91
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 90
Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins 90
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 89
ACTIONS OF RESOLVIN D1 AND D2 IN CYSTIC FIBROSIS MRSA LUNG INFECTION AND INFLAMMATION 89
Circulating endothelial progenitor cells and low-dose-aspirin-insensitive thromboxane biosynthesis in polycythemia rubra vera. 87
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis 87
Epigenetic regulation of the formyl peptide receptor 2 gene 86
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes 86
Homocysteine modulates the CD40/CD40L system 80
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 79
Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis 79
RESOLVINS, LIPOXINS, AND MARESINS IN RESOLUTION OF INFLAMMATION 77
Lipoxins and aspirin-triggered lipoxins in resolution of inflammation 77
Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review 76
Resolvin E1 receptor activation signals phosphorylation and phagocytosis. 76
PRORESOLVING AND ANTIMICROBIAL BIOACTIONS OF MELANOCORTINS ON CF CELLS 76
Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages. 73
Targeting caveolin-1 deficiency in bone marrow derived cells: A new therapeutic window for fibrotic diseases? 70
Resolution of sickle cell disease–associated inflammation and tissue damage with 17R-resolvin D1 69
Resolvin D1 and its GPCRs in resolution circuits of inflammation. 66
Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages 66
Resolvin D1 and Resolvin D2 Protect Against Hypoxia/Reoxygenation Induced Lung and Kidney Damage in a Sickle Cell Mouse Model of Acute Vaso-Occlusive Crisis 62
PROTECTIVE ROLE OF RVD1 AND ITS RECEPTOR IN CYSTIC FIBROSIS 58
Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation. 56
The Resolution Approach to Cystic Fibrosis Inflammation 52
Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. 51
null 44
Gene Expression of the D-Series Resolvin Pathway Predicts Activation of Anti-Tumor Immunity and Clinical Outcomes in Head and Neck Cancer 42
Impaired pro-resolving mechanisms promote abnormal NETosis, fueling autoimmunity in sickle cell disease 39
Roles of specialized pro-resolving lipid mediators in autophagy and inflammation 39
Specialized pro-resolving lipid mediators and resolution of viral diseases 33
Resolvins Modulate Netosis and Autoimmunity in Sickle Cell Disease 33
In Humanized Sickle Cell Mice, Imatinib Protects Against Sickle Cell-Related Injury 31
Reduced platelet glycoprotein Ibα shedding accelerates thrombopoiesis and COX-1 recovery: implications for aspirin dosing regimen 28
17R-Resolvin D1 Improves Inflammatory Cardiomyopathy in a Mouse Model of Sickle Cell Disease 26
Mitapivat, a pyruvate kinase activator, improves transfusion burden and reduces iron overload in β-thalassemic mice 24
Resolvin D1 reduces cystic fibrosis lung disease and inflammation associated with mucus obstruction 22
Maternal, newborn and breast milk concentrations of elexacaftor/tezacaftor/ivacaftor in a F508del heterozygous woman with cystic fibrosis following successful pregnancy 22
Single cell–level pro-resolving actions of Resolvin D1 and D2 on Staphylococcus aureus lung infection and inflammation in cystic fibrosis 22
Mitapivat reprograms the RBC metabolome and improves anemia in a mouse model of hereditary spherocytosis 18
Targeting platelet activation with pro-resolving mediators: an innovative strategy to dampen lung inflammation in cystic fibrosis 17
REPURPOSING GALLIUM FOR LOCAL TREATMENT OF BACTERIAL PNEUMONIA THROUGH INHALABLE NANO-EMBEDDED MICROPARTICLES 17
Development and application of a liquid chromatography–mass spectrometry method for monitoring CFTR modulators in biological fluids: a step forward in personalized CF treatment 16
Nrf2 Plays a Key Role in Erythropoiesis during Aging 15
Immunoregulatory mechanisms of the arachidonic acid pathway in cancer 6
Totale 4.931
Categoria #
all - tutte 21.519
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.519


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202075 0 0 0 0 0 0 0 0 0 0 67 8
2020/2021453 39 9 55 20 33 67 15 14 109 46 15 31
2021/2022344 5 10 2 88 15 11 6 22 19 15 26 125
2022/2023958 72 133 61 105 88 170 49 64 146 12 32 26
2023/2024649 54 32 37 26 35 193 97 55 7 29 19 65
2024/20251.133 74 241 147 53 85 68 113 110 122 83 37 0
Totale 4.931